Title: An S, et al. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs. EBioMedicine. 2018 Oct;36:553-562
1017606-58-4
113534-02-4
122734-32-1
120-43-4
14000-66-9
140447-78-5
1147350-75-1 | Thieno[3,2-c]pyridine-5(4H)-acetic acid, α-(2-chlorophenyl)-2,6,7,7a-tetrahydro-2-oxo-, methyl ester, (αS)- | AA000F14 | MFCD26793853
1149388-20-4 | Benzoic acid, 4-bromo-3-methoxy-2-methyl-, methyl ester | AA000FE7 | MFCD16658635
1150164-86-5 | 4,7-Dichloro-8-fluoro-2-(trifluoromethyl)quinoline | AA000FLM | MFCD12026031
1150655-12-1 | Potassium 2-fluoro-4-(trifluoromethyl)phenyltrifluoroborate | AA000FRT | MFCD07781236
115109-65-4 | Fmoc-pal-linker | AA000G7S | MFCD00236731
115297-57-9 | 4-Chlorobenzamidine hydroiodide | AA000GHL | MFCD00051987
1158758-60-1 | tert-Butyl 3-amino-3-ethylpyrrolidine-1-carboxylate | AA000GX3 | MFCD12408545
1159692-99-5 | (1H-Indol-2-yl)methanamine hydrochloride | AA000H5F | MFCD08437633
116-17-6 | Phosphorous acid, tris(1-methylethyl) ester | AA000HCP | MFCD00008874
1190423-36-9 | 2-(N,N-BisBOC-Amino)pyrimidine-5-boronic acid, pinacol ester | AA000I0W | MFCD12913985